14
Participants
Start Date
May 31, 2012
Primary Completion Date
September 30, 2013
Study Completion Date
October 31, 2013
Collagenase Clostridium Histolyticum
This is a dose escalation study in which subjects will sequentially receive single injections of 0.058 mg, 0.15 mg, 0.29 mg, 0.44 mg.
Zachary E. Gerut, M.D., Hewlett
Advance Biofactures Corporation
INDUSTRY
Zachary Gerut
INDIV